Bloggers

Lisa Banket
Cofounding Partner/Publisher
VIEW MY COMPLETE PROFILE
Taren Grom
Cofounding Partner/Editor-in-Chief
VIEW MY COMPLETE PROFILE
Heather Hummel
Project Coordinator
VIEW MY COMPLETE PROFILE
Dan Limbach
Producer, Webcast Network
VIEW MY COMPLETE PROFILE
Denise Myshko
Managing Editor
VIEW MY COMPLETE PROFILE
Kim Ribbink
Features Editor
VIEW MY COMPLETE PROFILE
Robin Robinson
Senior Editor
VIEW MY COMPLETE PROFILE
Marah Walsh
Cofounding Partner/New Business Development
VIEW MY COMPLETE PROFILE

PharmaVOICE Editors' Blog

Friday, April 11, 2014

April Feature Article - C-Suite: CROs: Opportunities and Barriers to Clinical Innovation

PharmaVOICE, Theorem

We asked c-suite executives throughout the CRO arena to provide their insights on what the biggest opportunities and barriers for innovation are for improving the drug development process, as well as identify a recent innovation that is improving the process.

Insights from John Potthoff Ph.D., President and CEO, Theorem Clinical Research.


Opportunities: Clinical trials today generate vast quantities of data that must be understood before they can be acted upon. The greatest opportunity for innovation in clinical development of biopharmaceuticals and medical devices lies in advanced software tools and techniques that allow real-time visualization of information in ways that speed understanding. In an era of risk-based monitoring and continual fine-tuning of trial design, connecting data streams with data visualization techniques provides a way for scientists to “see” multiple levels of data as they are generated, revealing new insights that can lead to better choices and decisions. As more and more data sources become available, this ability to visualize data will lead to an even deeper understanding of patients, products, and processes.


PharmaVOICE Feature Article April 2014


Read full article at http://bit.ly/pvdig38